Featured Stories
Ropes and Gray: Life Sciences and Health Care Partners Author Global Drug Pricing and Market Access Chapter in Pharmaceutical Pricing & Reimbursement 2026
BOSTON, Massachusetts, Sept. 5 -- Ropes and Gray, a law firm, issued the following news:
* * *
Life Sciences and Health Care Partners Author Global Drug Pricing and Market Access Chapter in Pharmaceutical Pricing & Reimbursement 2026
Ropes & Gray partners Lincoln Tsang, Eve Brunts and Katherine Wang co-authored the book chapter entitled "Global Drug Pricing and Market Access: The New Era of Cost Containment, Innovation, and Patient Access," in Global Legal Insights Pharmaceutical Pricing & Reimbursement 2026.
The global pharmaceutical industry stands at a pivotal crossroads, challenged to
... Show Full Article
BOSTON, Massachusetts, Sept. 5 -- Ropes and Gray, a law firm, issued the following news:
* * *
Life Sciences and Health Care Partners Author Global Drug Pricing and Market Access Chapter in Pharmaceutical Pricing & Reimbursement 2026
Ropes & Gray partners Lincoln Tsang, Eve Brunts and Katherine Wang co-authored the book chapter entitled "Global Drug Pricing and Market Access: The New Era of Cost Containment, Innovation, and Patient Access," in Global Legal Insights Pharmaceutical Pricing & Reimbursement 2026.
The global pharmaceutical industry stands at a pivotal crossroads, challenged todeliver cutting-edge therapies while ensuring affordability and broad patient access. Rapid innovation--especially in oncology, rare diseases, and chronic conditions--has transformed treatment landscapes, but the financial sustainability of health systems is under intense strain. The COVID-19 pandemic and ongoing geopolitical disruptions have exposed vulnerabilities in medicine supply chains, prompting governments and payors to prioritize supply security, diversify sourcing, and reinforce procurement frameworks. Escalating healthcare costs, aging populations, and the high prices of novel medicines are pushing policymakers to deploy a diverse arsenal of cost-containment strategies. These include direct price negotiations, international reference pricing, value-based reimbursement, and mandates for greater transparency.
Pharmaceutical companies now operate in a volatile environment where launch strategies, pricing models, and investment decisions face constant scrutiny. Risks of launch delays, product withdrawals, and market fragmentation are rising--especially in smaller or lower-priced markets. Traditional procurement models focused on lowest price are being reimagined. Today, broader value criteria--such as patient-reported outcomes and real-world effectiveness--are central to pricing and reimbursement decisions. Regulatory frameworks increasingly emphasize "most economically advantageous tender" (MEAT) criteria, balancing cost with qualitative benefits like supply resilience and patient experience.
In the United States, cost containment has become a policy centerpiece. The Most Favored Nation (MFN) pricing model and international reference pricing programs (e.g., GENEROUS, GLOBE, GUARD) benchmark US drug prices against those in other developed nations. The Inflation Reduction Act (IRA) empowers the federal government to negotiate prices for high-cost Medicare medicines, delivering substantial discounts and lowering patient out-of-pocket expenses. These reforms are reshaping global launch sequencing, as manufacturers reconsider launches in lower-priced countries to avoid price convergence. Legal challenges to US policies have failed, and new regulations targeting pharmacy benefit managers are increasing transparency and reducing patient costs. Direct-to-consumer discount models are also gaining traction, empowering patients to access affordable medicines.
Europe faces its own complexities. Fragmented pricing and reimbursement systems are under pressure from US reference pricing, leading to increased launch delays and product withdrawals. The UK has responded with a bilateral trade deal with the US, raising its cost-effectiveness threshold and capping rebate rates, though concerns persist about NHS spending and the robustness of cost-effectiveness assessments. The EU is advancing major legislative reforms--the Pharma Package, Critical Medicines Act (CMA), and EU Biotech Act--to boost competitiveness, strengthen supply chains, and incentivize local research and production. The new EU Health Technology Assessment Regulation (HTAR) introduces a Joint Clinical Assessment process, raising evidence standards and harmonizing requirements across Member States. Despite these efforts, challenges such as flat pharmaceutical spending, low venture capital investment, and threats to confidential discount mechanisms remain.
China is forging its own path, expanding access to innovative medicines through the National Healthcare Security Administration (NHSA) and the National Reimbursement Drug List (NRDL). The introduction of a new Category C for highly innovative drugs, covered by commercial insurance, reflects China's dual focus on affordability and innovation. Price negotiations and volume-based procurement continue to drive down costs but concerns about supply sustainability and investment in innovation persist.
Across all regions, the drive for pricing transparency, value-based care, and resilient supply chains is intensifying. Policymakers, payors, and industry leaders must navigate a complex web of trade-offs to ensure affordable access, reward innovation, and sustain healthcare systems. The future of global drug pricing and market access hinges on the ability of governments and industry to collaborate, adapt, and innovate in an interconnected, cost-conscious world.
* * *
Original text here: https://www.ropesgray.com/en/news-and-events/news/2026/09/life-sciences-and-health-care-partners-author-global-drug-pricing-and-market-access
[Category: BizLaw/Legal]
Ropes & Gray Advises Partners Group on Its Investment in AtNorth's Next Phase of Growth
BOSTON, Massachusetts, Sept. 5 -- Ropes and Gray, a law firm, issued the following news:
* * *
Ropes & Gray Advises Partners Group on its Investment in atNorth's Next Phase of Growth
Ropes & Gray has advised Partners Group (acting on behalf of its clients), one of the largest firms in the global private markets industry, on its investment in the next phase of growth for atNorth, a leading pan-Nordic data center platform. Partners Group's infrastructure secondaries strategy will acquire around 10% of atNorth.
Partners Group originally acquired atNorth in 2022 through its infrastructure directs
... Show Full Article
BOSTON, Massachusetts, Sept. 5 -- Ropes and Gray, a law firm, issued the following news:
* * *
Ropes & Gray Advises Partners Group on its Investment in atNorth's Next Phase of Growth
Ropes & Gray has advised Partners Group (acting on behalf of its clients), one of the largest firms in the global private markets industry, on its investment in the next phase of growth for atNorth, a leading pan-Nordic data center platform. Partners Group's infrastructure secondaries strategy will acquire around 10% of atNorth.
Partners Group originally acquired atNorth in 2022 through its infrastructure directsstrategy, transforming it into a leading next-generation platform with eight operational data centers alongside several sites under development across the Nordics. atNorth has over 1.5 GW of secured power with a considerable amount of planned additional future capacity and a robust demand pipeline that is set to benefit from continued AI-driven growth.
Partners Group's infrastructure secondaries strategy has a track record of investing in data centers. In 2024, the strategy acquired a minority stake in eStruxture, a leading data center platform in Canada, which the Ropes & Gray team also advised on.
Partners Group recently held the final close of its infrastructure secondaries program at over $5.5 billion, which represented one of the largest dedicated infrastructure secondaries fundraises in the industry at the time.
The Ropes & Gray team was led by asset management partners Tom Alabaster and Chris Townsend with support from tax partner Andrew Howard, asset management associates Madalina Asandului and August Jones-Loiacono, and tax associate Tim Waters.
* * *
Original text here: https://www.ropesgray.com/en/news-and-events/news/2026/09/ropes-gray-advises-partners-group-investment-atnorth-next-phase-of-growth
[Category: BizLaw/Legal]
Pillsbury Secures Unanimous First Department Victory in Beach vs. Touradji Capital Management
NEW YORK, Sept. 5 -- Pillsbury, a law firm, issued the following news release:
* * *
Pillsbury Secures Unanimous First Department Victory in Beach v. Touradji Capital Management
Pillsbury secured a significant victory in the Appellate Division, First Department, in Beach v. Touradji Capital Management, LP, a nearly two-decade dispute arising from former employees' claims for compensation from a commodities hedge fund.
In a unanimous decision, the First Department reversed the trial court's post-trial order, denied the defendants' motion under CPLR 4404(a) and reinstated the jury's verdict rejecting
... Show Full Article
NEW YORK, Sept. 5 -- Pillsbury, a law firm, issued the following news release:
* * *
Pillsbury Secures Unanimous First Department Victory in Beach v. Touradji Capital Management
Pillsbury secured a significant victory in the Appellate Division, First Department, in Beach v. Touradji Capital Management, LP, a nearly two-decade dispute arising from former employees' claims for compensation from a commodities hedge fund.
In a unanimous decision, the First Department reversed the trial court's post-trial order, denied the defendants' motion under CPLR 4404(a) and reinstated the jury's verdict rejectingall five of their counterclaims: breach of fiduciary duty, aiding and abetting breach of fiduciary duty, unfair competition, misappropriation of trade secrets and defamation.
The First Department agreed with the plaintiffs that there was no legally sufficient basis to disturb the jury's verdict. The court concluded that the defendants' "inextricably interwoven" theory lacked support under the CPLR and governing case law, and that overlapping facts alone did not entitle them to retry counterclaims the jury had unequivocally rejected. It further held that the possibility of inconsistent findings in a future trial was merely theoretical and did not justify depriving the plaintiffs of the benefit of their favorable verdict.
Additionally, the court agreed that the jury was entitled to credit Gentry Beach's testimony that he did not publish the report at issue and held that the trial court improperly overturned the jury's rejection of the defamation counterclaim against him.
The Pillsbury team representing the plaintiffs and counterclaim defendants included Litigation partner Rolando T. Acosta, associate Dante Apuzzo and senior law clerk Samyuktha Seth.
* * *
Original text here: https://www.pillsburylaw.com/en/news-and-insights/pillsbury-unanimous-first-department-victory-beach-v-touradji-capital-management.html
[Category: BizLaw/Legal]
Hughes Hubbard Wins New York Law Journal's Law Firm of the Year
NEW YORK, Sept. 5 -- Hughes Hubbard and Reed, a law firm, issued the following news:
* * *
Hughes Hubbard Wins New York Law Journal's Law Firm of the Year
Award honors a year of landmark victories, strategic deals and pro bono excellence.
Highlights
* Firm wins New York Law Journal's 2026 Law Firm of the Year: Midsize Firms.
* Secured landmark victories in high-stakes international litigations and disputes.
* Advised on significant cross-border M&A, restructuring, finance and capital markets transactions.
-
Hughes Hubbard has won Law Firm of the Year: Midsize Firms at the New York Law
... Show Full Article
NEW YORK, Sept. 5 -- Hughes Hubbard and Reed, a law firm, issued the following news:
* * *
Hughes Hubbard Wins New York Law Journal's Law Firm of the Year
Award honors a year of landmark victories, strategic deals and pro bono excellence.
Highlights
* Firm wins New York Law Journal's 2026 Law Firm of the Year: Midsize Firms.
* Secured landmark victories in high-stakes international litigations and disputes.
* Advised on significant cross-border M&A, restructuring, finance and capital markets transactions.
-
Hughes Hubbard has won Law Firm of the Year: Midsize Firms at the New York LawJournal's 2026 New York Legal Awards. The honor recognizes the firm's outstanding work for clients, including landmark recoveries in international litigation and advising on significant cross-border deals, as well as its pro bono work.
"We are honored to receive this recognition, which reflects the trust our clients around the world place in our outstanding lawyers and business professionals to deliver exceptional results," said Neil Oxford, Chair of Hughes Hubbard.
The award reflects a year of notable successes for the firm, including major litigation victories, high-profile cross-border transactions, complex restructuring matters and impactful pro bono work.
Among the firm's most significant litigation achievements were multiple victories for Denmark's tax authority, SKAT, including a nearly $500 million jury verdict, a $165 million bench trial judgment and settlements exceeding $450 million in ongoing international tax fraud litigation.
On the transactional side, Hughes Hubbard advised clients on a range of significant domestic and cross-border matters, including Grab Holdings' acquisition of Stash Financial, Allianz X's investment in Cambridge Mobile Telematics and Flushing Financial Corp.'s merger with OceanFirst Financial Corp. The firm also counseled clients on notable capital markets, restructuring and finance transactions, including Securitize's business combination with Cantor Equity Partners II and several major airline restructurings and aircraft finance deals.
The firm's commitment to public service remained a hallmark of its practice. Hughes Hubbard lawyers represented pro bono clients in immigration, civil rights, criminal defense and housing matters, including work supporting the Peter Kreguer Clinic and other community-focused initiatives. The firm also joined the Legal Aid Society and others in filing suit against New York State over inadequate shelter allowances.
"Our success is driven by the talent and commitment of our people," said Robb Patryk, Managing Partner of Hughes Hubbard. "This recognition celebrates a year of exceptional client results, strategic growth and continued investment in the firm and our future."
The New York Legal Awards celebrate attorneys, judges and organizations whose work has made a meaningful impact on the legal profession and the communities they serve. Hughes Hubbard was honored during the publication's annual awards program in New York.
* * *
Original text here: https://www.hugheshubbard.com/news-insights/news/hughes-hubbard-wins-new-york-law-journal-s-law-firm-of-the-year
[Category: BizLaw/Legal]
Dentons Advises MBank on Financing for 62.7 MW Polish Solar Portfolio
WASHINGTON, Sept. 5 -- Dentons, a law firm, issued the following news:
* * *
Dentons advises mBank on financing for 62.7 MW Polish solar portfolio
Dentons has advised mBank, acting as lender, on the financing of Project Vistula, a 62.7 MW portfolio of solar photovoltaic projects in Poland developed by London-based independent power platform Gulermak Renewables.
The PLN 152.9 million financing will support the construction and operation of five solar assets: Brodnica I and II, Glinnik I and II, and Powidz. All projects are currently under construction, with Powidz expected to be the first to
... Show Full Article
WASHINGTON, Sept. 5 -- Dentons, a law firm, issued the following news:
* * *
Dentons advises mBank on financing for 62.7 MW Polish solar portfolio
Dentons has advised mBank, acting as lender, on the financing of Project Vistula, a 62.7 MW portfolio of solar photovoltaic projects in Poland developed by London-based independent power platform Gulermak Renewables.
The PLN 152.9 million financing will support the construction and operation of five solar assets: Brodnica I and II, Glinnik I and II, and Powidz. All projects are currently under construction, with Powidz expected to be the first toenter commercial operation later this year.
The financing establishes a repeatable framework to support Gulermak Renewables' continued expansion in Poland and selected other European markets. The successful financial close is underpinned by a dual revenue structure: a government-guaranteed contract for difference providing long-term contracted revenue, complemented by a multi-site route-to-market agreement with Hekla Energy covering Brodnica and Powidz and running through to 2030.
The mBank team included Gracjan Biskup, Piotr Ziopaja and Daniel Uscimiak, while the Gulermak Renewables team included Turkekul Dogan, Zeyp Kurt, Beyza Sirkeci, Patrycja Bojdo and Menelaos Vakalopoulos.
Dentons' services were supervised by Adriana Mierzwa-Bronikowska, partner and head of the Projects practice in the Warsaw office. Managing counsel Aleksander Haleniuk led the work on the preparation, negotiation and execution of the finance documents, supported by associate Monika Niedopytala.
Managing counsel Maciej Ziolkowski led the due diligence work on the transaction, supported by associates Gracjan Bielawski, Zofia Szewczuk and Bartlomiej Ksiazek. Energy-related work was supervised by Piotr Ciolkowski, partner and co-head of the Energy and Natural Resources practice.
Senior associate Bartlomiej Slemp and associate Kacper Miller were responsible for drafting bankable EPC contracts with the general contractor and the subcontractor.
* * *
About Dentons
Redefining possibilities. Together, everywhere. For more information visit dentons.com
* * *
URL: mBank
* * *
Original text here: https://www.dentons.com/en/about-dentons/news-events-and-awards/news/2026/september/dentons-advises-mbank-on-financing-for-62-7-mw-polish-solar-portfolio
[Category: BizLaw/Legal]
Dentons Advises Equans UK & Ireland on Its Acquisition of Mway Communications
WASHINGTON, Sept. 5 -- Dentons, a law firm, issued the following news:
* * *
Dentons advises Equans UK & Ireland on its acquisition of Mway Communications
London--Dentons has advised Equans UK & Ireland on its strategic acquisition of Mway Communications, a leading specialist in highways technology and communications infrastructure.
Mway provides critical technology and engineering solutions to National Highways and Tier 1 contractors across the UK's Strategic Road Network. The business employs around 100 people and generates annual turnover of approximately pound sterling26 million.
The acquisition
... Show Full Article
WASHINGTON, Sept. 5 -- Dentons, a law firm, issued the following news:
* * *
Dentons advises Equans UK & Ireland on its acquisition of Mway Communications
London--Dentons has advised Equans UK & Ireland on its strategic acquisition of Mway Communications, a leading specialist in highways technology and communications infrastructure.
Mway provides critical technology and engineering solutions to National Highways and Tier 1 contractors across the UK's Strategic Road Network. The business employs around 100 people and generates annual turnover of approximately pound sterling26 million.
The acquisitionstrengthens Equans' UK capabilities in connected infrastructure, operational technology and communications networks. Mway's services span technology deployment, electrical engineering, street lighting, traffic signals, inductive loop installation and highways civil works, complementing Equans' existing capabilities across digital infrastructure, energy systems, engineering and asset management.
James Graham, Divisional CEO at Equans UK & Ireland, said: "Mway Communications has built an excellent reputation as a trusted delivery partner across the UK's Strategic Road Network. Their deep sector knowledge and proven customer partnerships make them excellent in their operation. We are delighted to welcome the Mway team to Equans. We would also like to thank the Dentons team for the commercial and pragmatic advice throughout the transaction."
Chris Colclough, Partner in Dentons' UK Corporate team, said: "We are delighted to have supported Equans on this strategic acquisition. Mway is a high-quality business operating at the heart of the UK's critical highways infrastructure, and its specialist technology and engineering capabilities make it a compelling addition to Equans' existing platform. The transaction reflects the continued investment we are seeing in connected and technology-enabled infrastructure across the UK. It was a real pleasure to work with the Equans team and support them in delivering the acquisition."
The Dentons team was led by Chris Colclough, Partner and Head of the Milton Keynes Corporate team, supported by Senior Associate Chris Northway, Associate Emily Bowler and Trainee Mayowa Olagunju, working alongside a multidisciplinary team of Dentons specialists including Rukia Khatun and Lily Folland (Technology, Media and Telecommunications), Jamie MacGregor (Tax), Verity Buckingham (Employment) and Chris De Luca (Real Estate).
* * *
About Dentons
Redefining possibilities. Together, everywhere. For more information visit dentons.com
* * *
URL: Equans UK & Ireland
* * *
Original text here: https://www.dentons.com/en/about-dentons/news-events-and-awards/news/2026/september/dentons-advises-equans-uk-and-ireland-on-acquisition-of-mway-communications
[Category: BizLaw/Legal]
Clark Hill: CARB Releases New Resources and Reporting Guidance for California SB 253 Compliance
BIRMINGHAM, Michigan, Sept. 5 -- Clark Hill, a law firm, issued the following legal update:
* * *
CARB Releases New Resources and Reporting Guidance for California SB 253 Compliance
Author: Maram T. Salaheldin
The California Air Resources Board ("CARB") recently released several resources to assist companies preparing for the first reporting cycle under California's Climate Corporate Data Accountability Act ("SB 253"). The new materials include a voluntary reporting intake platform, plus a video tutorial, that gives reporting entities an opportunity to voluntarily provide CARB with entity information,
... Show Full Article
BIRMINGHAM, Michigan, Sept. 5 -- Clark Hill, a law firm, issued the following legal update:
* * *
CARB Releases New Resources and Reporting Guidance for California SB 253 Compliance
Author: Maram T. Salaheldin
The California Air Resources Board ("CARB") recently released several resources to assist companies preparing for the first reporting cycle under California's Climate Corporate Data Accountability Act ("SB 253"). The new materials include a voluntary reporting intake platform, plus a video tutorial, that gives reporting entities an opportunity to voluntarily provide CARB with entity information,including regarding in-scope subsidiaries and contact information for fee invoicing for 2026. The materials also include a new guidance document for SB 253 2026 reporting submittals. These updates provide additional insight into CARB's expectations for the inaugural reporting year, but uncertainty remains as CARB's resubmitted Initial Regulation awaits approval by the Office of Administrative Law ("OAL") and litigation continues.
Anticipated Timeline
Although the Initial Regulation remains subject to final approval by the OAL, CARB continues to move forward with implementation efforts and has begun providing operational guidance to affected companies. Under CARB's proposed Initial Regulation, as reiterated by CARB through its recent guidance materials, companies expect the following timeline:
Reporting entities will be required to submit Scope 1 and Scope 2 greenhouse gas ("GHG") emissions data by November 10, 2026.
CARB will send fee invoices on or before December 10, 2026.
Payment will be due within 60 calendar days from the date of CARB's invoice.
The Voluntary Reporting Intake Platform
CARB's 2026 Voluntary Reporting Intake Platform allows reporting entities to provide contact and billing information to CARB in advance of reporting deadlines and, if desired, submit Scope 1 and Scope 2 emissions reports directly through the platform. Use of the platform is entirely voluntary, and CARB indicates that entities may also submit data by emailing climatedisclosure@arb.ca.gov. CARB's video tutorial provides a full walk-through of the platform.
CARB indicates that the platform is intended to streamline first-year reporting and fee administration. Besides contact information for fee invoicing purposes, the platform also enables companies to submit information on their different entities (e.g., subsidiaries) that have been determined to be in the scope of SB 253 and to indicate whether they will report on a consolidated basis and whether they wish to receive one invoice for all applicable fees. For example, one in-scope parent company may opt to pay one invoice covering three sets of fees for itself and its two in-scope subsidiaries.
Companies considering use of the platform should note an important practical consideration, however: the platform states that uploaded emissions reports and statements of non-reporting (for entities not reporting based on the December 2024 Enforcement Notice) will be made public. Therefore, reporting entities should carefully evaluate any information they intend to submit through the system and consider whether a different approach may be more appropriate in certain circumstances.
CARB's New Reporting Guidance Document
CARB's new guidance document reiterates the guidance in its prior Frequently Asked Questions ("FAQ") and the enforcement discretion first announced in its December 2024 Enforcement Notice. For the initial 2026 reporting cycle, CARB will accept Scope 1 and Scope 2 emissions data based on information that entities were already collecting, or were planning to collect, at the time of the notice. CARB also confirms that limited assurance will not be required for first-year submissions, notwithstanding SB 253's statutory assurance requirements.
The guidance document also addresses applicability criteria and key definitions, acceptable formats for 2026 reporting, Scope 2 emission factor options, reporting requirements for 2027 and beyond.
Looking Ahead
CARB's latest guidance provides some clarity for companies preparing for the first year of SB 253 reporting, but significant questions remain. Companies that may be subject to SB 253 should continue evaluating applicability based on the proposed Initial Regulation and, if in-scope, make a plan for how to approach the expected November 10, 2026 reporting deadline, including whether to begin voluntarily submitting entity information to CARB to streamline consolidated reporting and fee invoicing if applicable. At the same time, it is important to continue monitoring related developments, including the pending litigation, and maintain an adaptable and strategic approach to compliance planning.
Clark Hill's ESG & Sustainability team consists of attorneys and professionals throughout the U.S., Mexico, and Ireland representing a range of primary practice areas intersecting with ESG and sustainability issues. If you have questions or would like to discuss this alert, please contact the authors directly or your usual Clark Hill contact.
* * *
This publication is intended for general informational purposes only and does not constitute legal advice or a solicitation to provide legal services. The information in this publication is not intended to create, and receipt of it does not constitute, a lawyer-client relationship. Readers should not act upon this information without seeking professional legal counsel. The views and opinions expressed herein represent those of the individual author(s) only and are not necessarily the views of Clark Hill PLC. Although we attempt to ensure that postings on our website are complete, accurate, and up to date, we assume no responsibility for their completeness, accuracy, or timeliness.
* * *
Original text here: https://www.clarkhill.com/news-events/news/carb-releases-new-resources-and-reporting-guidance-for-california-sb-253-compliance/
[Category: BizLaw/Legal]
